Annual Shareholder's Meeting Results, Director Announcements and Director Independence


Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that all resolutions put to the company’s annual shareholders’ meeting held in Auckland today were passed. The six resolutions were:

Resolution 1: To elect Donal O’Dwyer as a Director.

Resolution 2: To elect Geraldine McBride as a Director.

Resolution 3: To authorise the Directors to fix the fees and expenses of the Company’s auditor.

Resolution 4: To approve the issue of share rights to Michael Daniell as set out in the Notice of Annual Shareholders’ Meeting 2013.

Resolution 5: To approve the issue of options to Michael Daniell as set out in the Notice of Annual Shareholders’ Meeting 2013.

Resolution 6: To approve the Fisher & Paykel Healthcare (North America) Share Option Plan and the Fisher & Paykel Healthcare Performance Share Rights Plan.

All resolutions were decided by poll. The details of the total number of votes cast in person or by proxy on the polls were as follows:

Resolution Votes For Votes Against Total Votes Cast Abstain
Resolution 1: Election of Donal O’Dwyer 339,478,969 129,357 339,608,326 198,602
Resolution 2: Election of Geraldine McBride 339,457,973 139,266 339,597,239 209,689
Resolution 3: Authorise Directors to fix fees and expenses of auditor 339,571,472 60,906 339,632,378 174,550
Resolution 4: Issue of share rights to Michael Daniell 335,716,826 2,232,163 337,948,989 1,825,199
Resolution 5: Issue of options to Michael Daniell 318,074,567 19,859,527 337,934,094 1,870,234
Resolution 6: Approval of Fisher & Paykel Healthcare Corporation Limited Stock Purchase Plan 335,858,431 3,613,018 339,471,449 339,879
 

Announcement regarding Directors
Gary Paykel and Nigel Evans retired from the board at the company’s 2013 annual shareholders’ meeting. The Board has appointed Lindsay Gillanders to the company’s Audit & Risk Committee to fill the vacancy left following the retirement of Nigel Evans.

Consequently, the Board has appointed Geraldine McBride to the company’s Remuneration and Human Resources Committee to replace Lindsay Gillanders who will be stepping down from the Remuneration and Human Resources Committee to take up the appointment to the company’s Audit & Risk Committee.

Independence of Directors
In accordance with NZX Listing Rule 3.3.3(a), the Board has determined that Tony Carter, Nigel Evans, Roger France, Lindsay Gillanders, Geraldine McBride, Arthur Morris and Donal O’Dwyer are independent directors.

The factors that the Board considers in assessing the independence of directors are set out in the Board Charter, which can be viewed on the company’s website: www.fphcare.com.

Contact: Tony Barclay, Company Secretary on +64 9 574 0119. For more information about the company visit our website www.fphcare.com

 

About Fisher & Paykel Healthcare

Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Ends

 

Contact

Investors:

Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073

 

Media:

Karen Knott
Senior Communications Manager
karen.knott@fphcare.co.nz
+64 (0) 21 713 911